SEC Form 4 · accession 0001615774-17-005261
Emmaus Life Sciences, Inc. · EMMA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter Unanue
Director
Period of report
Sep 19, 2017
Accepted (ET)
Sep 21, 2017 · 8:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000822370
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 19, 2017 | A | 12,000 | $0.00 | A | 50,100 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Director Stock Option (right to buy)F1 | $3.60 | Sep 19, 2017 | A | 12,000 | A | — | Sep 19, 2027 | Common Stock | 12,000 | 12,000 | D |
Explanation of responses
- F1The option vests in four equal quarterly installments beginning on December 19, 2017.